Total planned funding: $756,660,385
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $154,834,536 |
Kenya | $116,572,780 |
Uganda | $105,990,702 |
Zambia | $94,436,033 |
Tanzania | $58,775,424 |
Mozambique | $40,327,658 |
Côte d'Ivoire | $30,889,391 |
Zimbabwe | $28,615,958 |
South Africa | $27,941,146 |
Rwanda | $23,496,250 |
Democratic Republic of the Congo | $18,368,446 |
Haiti | $17,060,973 |
Vietnam | $14,000,000 |
Botswana | $8,004,013 |
Ethiopia | $3,774,817 |
Burundi | $3,562,296 |
Guyana | $2,121,954 |
Namibia | $2,014,798 |
West Africa Region | $2,012,397 |
Cameroon | $1,351,971 |
Eswatini | $1,044,359 |
Western Hemisphere Region | $706,942 |
Lesotho | $482,041 |
Asia Regional Program | $175,500 |
Dominican Republic | $100,000 |
Organizational Types
Private Contractor | $561,271,966 |
NGO | $66,586,259 |
Unknown | $53,239,510 |
Host Country Government Agency | $41,926,376 |
Implementing Agency | $24,797,630 |
FBO | $3,719,692 |
University | $3,475,960 |
Parastatal | $1,073,626 |
Own Agency | $569,366 |
Program Areas
Treatment | $756,660,385 |
Budget Codes
HTXD: Treatment: ARV Drugs | $756,660,385 |
Top Partner Programs
Chemonics International:
$367,238,066
View countries